Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000912282-08-001303
Filing Date
2008-08-22
Accepted
2008-08-22 17:22:50
Documents
1
Period of Report
2008-08-21

Document Format Files

Seq Description Document Type Size
1 oncogen-cormack3_082108ex.html 3  
1 oncogen-cormack3_082108ex.xml 3 1515
  Complete submission text file 0000912282-08-001303.txt   3405
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 400-1001 WEST BROADWAY VANCOUVER A1 V6H 4B1
Business Address 604-736-3678
Cormack Scott Daniel (Reporting) CIK: 0001442675 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21243 | Film No.: 081035227